Global Antibodies Contract Manufacturing Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Antibodies Contract Manufacturing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Antibodies Contract Manufacturing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Antibodies Contract Manufacturing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Antibodies Contract Manufacturing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Antibodies Contract Manufacturing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Antibodies Contract Manufacturing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antibodies Contract Manufacturing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antibodies Contract Manufacturing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AMRI, AGC Biologics, Aldevron, Eurofins CDMO and Boehringer Ingelheim BioXcellence, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Antibodies Contract Manufacturing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Antibodies Contract Manufacturing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antibodies Contract Manufacturing, with revenue, gross margin and global market share of Antibodies Contract Manufacturing from 2018 to 2023.
Chapter 3, the Antibodies Contract Manufacturing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Antibodies Contract Manufacturing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Antibodies Contract Manufacturing.
Chapter 13, to describe Antibodies Contract Manufacturing research findings and conclusion.
This report is a detailed and comprehensive analysis for global Antibodies Contract Manufacturing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Antibodies Contract Manufacturing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Antibodies Contract Manufacturing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Antibodies Contract Manufacturing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Antibodies Contract Manufacturing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antibodies Contract Manufacturing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antibodies Contract Manufacturing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AMRI, AGC Biologics, Aldevron, Eurofins CDMO and Boehringer Ingelheim BioXcellence, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Antibodies Contract Manufacturing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Monoclonal Antibodies
- Antibody Fragments
- Polyclonal Antibodies
- SME
- Large Enterprise
- AMRI
- AGC Biologics
- Aldevron
- Eurofins CDMO
- Boehringer Ingelheim BioXcellence
- FUJIFILM Diosynth Biotechnologies
- Emergent BioSolutions
- KBI Biopharma
- Lonza
- Novasep
- Nitto Avecia Pharma Services
- Pierre Fabre
- Samsung BioLogics
- Synthon
- Thermo Fisher Scientific
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Antibodies Contract Manufacturing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antibodies Contract Manufacturing, with revenue, gross margin and global market share of Antibodies Contract Manufacturing from 2018 to 2023.
Chapter 3, the Antibodies Contract Manufacturing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Antibodies Contract Manufacturing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Antibodies Contract Manufacturing.
Chapter 13, to describe Antibodies Contract Manufacturing research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Antibodies Contract Manufacturing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Antibodies Contract Manufacturing by Type
1.3.1 Overview: Global Antibodies Contract Manufacturing Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Antibodies Contract Manufacturing Consumption Value Market Share by Type in 2022
1.3.3 Monoclonal Antibodies
1.3.4 Antibody Fragments
1.3.5 Polyclonal Antibodies
1.4 Global Antibodies Contract Manufacturing Market by Application
1.4.1 Overview: Global Antibodies Contract Manufacturing Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 SME
1.4.3 Large Enterprise
1.5 Global Antibodies Contract Manufacturing Market Size & Forecast
1.6 Global Antibodies Contract Manufacturing Market Size and Forecast by Region
1.6.1 Global Antibodies Contract Manufacturing Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Antibodies Contract Manufacturing Market Size by Region, (2018-2029)
1.6.3 North America Antibodies Contract Manufacturing Market Size and Prospect (2018-2029)
1.6.4 Europe Antibodies Contract Manufacturing Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Antibodies Contract Manufacturing Market Size and Prospect (2018-2029)
1.6.6 South America Antibodies Contract Manufacturing Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Antibodies Contract Manufacturing Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 AMRI
2.1.1 AMRI Details
2.1.2 AMRI Major Business
2.1.3 AMRI Antibodies Contract Manufacturing Product and Solutions
2.1.4 AMRI Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AMRI Recent Developments and Future Plans
2.2 AGC Biologics
2.2.1 AGC Biologics Details
2.2.2 AGC Biologics Major Business
2.2.3 AGC Biologics Antibodies Contract Manufacturing Product and Solutions
2.2.4 AGC Biologics Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AGC Biologics Recent Developments and Future Plans
2.3 Aldevron
2.3.1 Aldevron Details
2.3.2 Aldevron Major Business
2.3.3 Aldevron Antibodies Contract Manufacturing Product and Solutions
2.3.4 Aldevron Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Aldevron Recent Developments and Future Plans
2.4 Eurofins CDMO
2.4.1 Eurofins CDMO Details
2.4.2 Eurofins CDMO Major Business
2.4.3 Eurofins CDMO Antibodies Contract Manufacturing Product and Solutions
2.4.4 Eurofins CDMO Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Eurofins CDMO Recent Developments and Future Plans
2.5 Boehringer Ingelheim BioXcellence
2.5.1 Boehringer Ingelheim BioXcellence Details
2.5.2 Boehringer Ingelheim BioXcellence Major Business
2.5.3 Boehringer Ingelheim BioXcellence Antibodies Contract Manufacturing Product and Solutions
2.5.4 Boehringer Ingelheim BioXcellence Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Boehringer Ingelheim BioXcellence Recent Developments and Future Plans
2.6 FUJIFILM Diosynth Biotechnologies
2.6.1 FUJIFILM Diosynth Biotechnologies Details
2.6.2 FUJIFILM Diosynth Biotechnologies Major Business
2.6.3 FUJIFILM Diosynth Biotechnologies Antibodies Contract Manufacturing Product and Solutions
2.6.4 FUJIFILM Diosynth Biotechnologies Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.7 Emergent BioSolutions
2.7.1 Emergent BioSolutions Details
2.7.2 Emergent BioSolutions Major Business
2.7.3 Emergent BioSolutions Antibodies Contract Manufacturing Product and Solutions
2.7.4 Emergent BioSolutions Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Emergent BioSolutions Recent Developments and Future Plans
2.8 KBI Biopharma
2.8.1 KBI Biopharma Details
2.8.2 KBI Biopharma Major Business
2.8.3 KBI Biopharma Antibodies Contract Manufacturing Product and Solutions
2.8.4 KBI Biopharma Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 KBI Biopharma Recent Developments and Future Plans
2.9 Lonza
2.9.1 Lonza Details
2.9.2 Lonza Major Business
2.9.3 Lonza Antibodies Contract Manufacturing Product and Solutions
2.9.4 Lonza Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Lonza Recent Developments and Future Plans
2.10 Novasep
2.10.1 Novasep Details
2.10.2 Novasep Major Business
2.10.3 Novasep Antibodies Contract Manufacturing Product and Solutions
2.10.4 Novasep Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Novasep Recent Developments and Future Plans
2.11 Nitto Avecia Pharma Services
2.11.1 Nitto Avecia Pharma Services Details
2.11.2 Nitto Avecia Pharma Services Major Business
2.11.3 Nitto Avecia Pharma Services Antibodies Contract Manufacturing Product and Solutions
2.11.4 Nitto Avecia Pharma Services Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Nitto Avecia Pharma Services Recent Developments and Future Plans
2.12 Pierre Fabre
2.12.1 Pierre Fabre Details
2.12.2 Pierre Fabre Major Business
2.12.3 Pierre Fabre Antibodies Contract Manufacturing Product and Solutions
2.12.4 Pierre Fabre Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Pierre Fabre Recent Developments and Future Plans
2.13 Samsung BioLogics
2.13.1 Samsung BioLogics Details
2.13.2 Samsung BioLogics Major Business
2.13.3 Samsung BioLogics Antibodies Contract Manufacturing Product and Solutions
2.13.4 Samsung BioLogics Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Samsung BioLogics Recent Developments and Future Plans
2.14 Synthon
2.14.1 Synthon Details
2.14.2 Synthon Major Business
2.14.3 Synthon Antibodies Contract Manufacturing Product and Solutions
2.14.4 Synthon Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Synthon Recent Developments and Future Plans
2.15 Thermo Fisher Scientific
2.15.1 Thermo Fisher Scientific Details
2.15.2 Thermo Fisher Scientific Major Business
2.15.3 Thermo Fisher Scientific Antibodies Contract Manufacturing Product and Solutions
2.15.4 Thermo Fisher Scientific Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Thermo Fisher Scientific Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Antibodies Contract Manufacturing Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Antibodies Contract Manufacturing by Company Revenue
3.2.2 Top 3 Antibodies Contract Manufacturing Players Market Share in 2022
3.2.3 Top 6 Antibodies Contract Manufacturing Players Market Share in 2022
3.3 Antibodies Contract Manufacturing Market: Overall Company Footprint Analysis
3.3.1 Antibodies Contract Manufacturing Market: Region Footprint
3.3.2 Antibodies Contract Manufacturing Market: Company Product Type Footprint
3.3.3 Antibodies Contract Manufacturing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Antibodies Contract Manufacturing Consumption Value and Market Share by Type (2018-2023)
4.2 Global Antibodies Contract Manufacturing Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Antibodies Contract Manufacturing Consumption Value Market Share by Application (2018-2023)
5.2 Global Antibodies Contract Manufacturing Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Antibodies Contract Manufacturing Consumption Value by Type (2018-2029)
6.2 North America Antibodies Contract Manufacturing Consumption Value by Application (2018-2029)
6.3 North America Antibodies Contract Manufacturing Market Size by Country
6.3.1 North America Antibodies Contract Manufacturing Consumption Value by Country (2018-2029)
6.3.2 United States Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
6.3.3 Canada Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
6.3.4 Mexico Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Antibodies Contract Manufacturing Consumption Value by Type (2018-2029)
7.2 Europe Antibodies Contract Manufacturing Consumption Value by Application (2018-2029)
7.3 Europe Antibodies Contract Manufacturing Market Size by Country
7.3.1 Europe Antibodies Contract Manufacturing Consumption Value by Country (2018-2029)
7.3.2 Germany Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
7.3.3 France Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
7.3.5 Russia Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
7.3.6 Italy Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Antibodies Contract Manufacturing Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Antibodies Contract Manufacturing Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Antibodies Contract Manufacturing Market Size by Region
8.3.1 Asia-Pacific Antibodies Contract Manufacturing Consumption Value by Region (2018-2029)
8.3.2 China Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
8.3.3 Japan Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
8.3.4 South Korea Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
8.3.5 India Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
8.3.7 Australia Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Antibodies Contract Manufacturing Consumption Value by Type (2018-2029)
9.2 South America Antibodies Contract Manufacturing Consumption Value by Application (2018-2029)
9.3 South America Antibodies Contract Manufacturing Market Size by Country
9.3.1 South America Antibodies Contract Manufacturing Consumption Value by Country (2018-2029)
9.3.2 Brazil Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
9.3.3 Argentina Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Antibodies Contract Manufacturing Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Antibodies Contract Manufacturing Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Antibodies Contract Manufacturing Market Size by Country
10.3.1 Middle East & Africa Antibodies Contract Manufacturing Consumption Value by Country (2018-2029)
10.3.2 Turkey Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
10.3.4 UAE Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Antibodies Contract Manufacturing Market Drivers
11.2 Antibodies Contract Manufacturing Market Restraints
11.3 Antibodies Contract Manufacturing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Antibodies Contract Manufacturing Industry Chain
12.2 Antibodies Contract Manufacturing Upstream Analysis
12.3 Antibodies Contract Manufacturing Midstream Analysis
12.4 Antibodies Contract Manufacturing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Antibodies Contract Manufacturing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Antibodies Contract Manufacturing by Type
1.3.1 Overview: Global Antibodies Contract Manufacturing Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Antibodies Contract Manufacturing Consumption Value Market Share by Type in 2022
1.3.3 Monoclonal Antibodies
1.3.4 Antibody Fragments
1.3.5 Polyclonal Antibodies
1.4 Global Antibodies Contract Manufacturing Market by Application
1.4.1 Overview: Global Antibodies Contract Manufacturing Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 SME
1.4.3 Large Enterprise
1.5 Global Antibodies Contract Manufacturing Market Size & Forecast
1.6 Global Antibodies Contract Manufacturing Market Size and Forecast by Region
1.6.1 Global Antibodies Contract Manufacturing Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Antibodies Contract Manufacturing Market Size by Region, (2018-2029)
1.6.3 North America Antibodies Contract Manufacturing Market Size and Prospect (2018-2029)
1.6.4 Europe Antibodies Contract Manufacturing Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Antibodies Contract Manufacturing Market Size and Prospect (2018-2029)
1.6.6 South America Antibodies Contract Manufacturing Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Antibodies Contract Manufacturing Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 AMRI
2.1.1 AMRI Details
2.1.2 AMRI Major Business
2.1.3 AMRI Antibodies Contract Manufacturing Product and Solutions
2.1.4 AMRI Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AMRI Recent Developments and Future Plans
2.2 AGC Biologics
2.2.1 AGC Biologics Details
2.2.2 AGC Biologics Major Business
2.2.3 AGC Biologics Antibodies Contract Manufacturing Product and Solutions
2.2.4 AGC Biologics Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AGC Biologics Recent Developments and Future Plans
2.3 Aldevron
2.3.1 Aldevron Details
2.3.2 Aldevron Major Business
2.3.3 Aldevron Antibodies Contract Manufacturing Product and Solutions
2.3.4 Aldevron Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Aldevron Recent Developments and Future Plans
2.4 Eurofins CDMO
2.4.1 Eurofins CDMO Details
2.4.2 Eurofins CDMO Major Business
2.4.3 Eurofins CDMO Antibodies Contract Manufacturing Product and Solutions
2.4.4 Eurofins CDMO Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Eurofins CDMO Recent Developments and Future Plans
2.5 Boehringer Ingelheim BioXcellence
2.5.1 Boehringer Ingelheim BioXcellence Details
2.5.2 Boehringer Ingelheim BioXcellence Major Business
2.5.3 Boehringer Ingelheim BioXcellence Antibodies Contract Manufacturing Product and Solutions
2.5.4 Boehringer Ingelheim BioXcellence Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Boehringer Ingelheim BioXcellence Recent Developments and Future Plans
2.6 FUJIFILM Diosynth Biotechnologies
2.6.1 FUJIFILM Diosynth Biotechnologies Details
2.6.2 FUJIFILM Diosynth Biotechnologies Major Business
2.6.3 FUJIFILM Diosynth Biotechnologies Antibodies Contract Manufacturing Product and Solutions
2.6.4 FUJIFILM Diosynth Biotechnologies Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.7 Emergent BioSolutions
2.7.1 Emergent BioSolutions Details
2.7.2 Emergent BioSolutions Major Business
2.7.3 Emergent BioSolutions Antibodies Contract Manufacturing Product and Solutions
2.7.4 Emergent BioSolutions Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Emergent BioSolutions Recent Developments and Future Plans
2.8 KBI Biopharma
2.8.1 KBI Biopharma Details
2.8.2 KBI Biopharma Major Business
2.8.3 KBI Biopharma Antibodies Contract Manufacturing Product and Solutions
2.8.4 KBI Biopharma Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 KBI Biopharma Recent Developments and Future Plans
2.9 Lonza
2.9.1 Lonza Details
2.9.2 Lonza Major Business
2.9.3 Lonza Antibodies Contract Manufacturing Product and Solutions
2.9.4 Lonza Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Lonza Recent Developments and Future Plans
2.10 Novasep
2.10.1 Novasep Details
2.10.2 Novasep Major Business
2.10.3 Novasep Antibodies Contract Manufacturing Product and Solutions
2.10.4 Novasep Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Novasep Recent Developments and Future Plans
2.11 Nitto Avecia Pharma Services
2.11.1 Nitto Avecia Pharma Services Details
2.11.2 Nitto Avecia Pharma Services Major Business
2.11.3 Nitto Avecia Pharma Services Antibodies Contract Manufacturing Product and Solutions
2.11.4 Nitto Avecia Pharma Services Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Nitto Avecia Pharma Services Recent Developments and Future Plans
2.12 Pierre Fabre
2.12.1 Pierre Fabre Details
2.12.2 Pierre Fabre Major Business
2.12.3 Pierre Fabre Antibodies Contract Manufacturing Product and Solutions
2.12.4 Pierre Fabre Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Pierre Fabre Recent Developments and Future Plans
2.13 Samsung BioLogics
2.13.1 Samsung BioLogics Details
2.13.2 Samsung BioLogics Major Business
2.13.3 Samsung BioLogics Antibodies Contract Manufacturing Product and Solutions
2.13.4 Samsung BioLogics Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Samsung BioLogics Recent Developments and Future Plans
2.14 Synthon
2.14.1 Synthon Details
2.14.2 Synthon Major Business
2.14.3 Synthon Antibodies Contract Manufacturing Product and Solutions
2.14.4 Synthon Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Synthon Recent Developments and Future Plans
2.15 Thermo Fisher Scientific
2.15.1 Thermo Fisher Scientific Details
2.15.2 Thermo Fisher Scientific Major Business
2.15.3 Thermo Fisher Scientific Antibodies Contract Manufacturing Product and Solutions
2.15.4 Thermo Fisher Scientific Antibodies Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Thermo Fisher Scientific Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Antibodies Contract Manufacturing Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Antibodies Contract Manufacturing by Company Revenue
3.2.2 Top 3 Antibodies Contract Manufacturing Players Market Share in 2022
3.2.3 Top 6 Antibodies Contract Manufacturing Players Market Share in 2022
3.3 Antibodies Contract Manufacturing Market: Overall Company Footprint Analysis
3.3.1 Antibodies Contract Manufacturing Market: Region Footprint
3.3.2 Antibodies Contract Manufacturing Market: Company Product Type Footprint
3.3.3 Antibodies Contract Manufacturing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Antibodies Contract Manufacturing Consumption Value and Market Share by Type (2018-2023)
4.2 Global Antibodies Contract Manufacturing Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Antibodies Contract Manufacturing Consumption Value Market Share by Application (2018-2023)
5.2 Global Antibodies Contract Manufacturing Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Antibodies Contract Manufacturing Consumption Value by Type (2018-2029)
6.2 North America Antibodies Contract Manufacturing Consumption Value by Application (2018-2029)
6.3 North America Antibodies Contract Manufacturing Market Size by Country
6.3.1 North America Antibodies Contract Manufacturing Consumption Value by Country (2018-2029)
6.3.2 United States Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
6.3.3 Canada Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
6.3.4 Mexico Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Antibodies Contract Manufacturing Consumption Value by Type (2018-2029)
7.2 Europe Antibodies Contract Manufacturing Consumption Value by Application (2018-2029)
7.3 Europe Antibodies Contract Manufacturing Market Size by Country
7.3.1 Europe Antibodies Contract Manufacturing Consumption Value by Country (2018-2029)
7.3.2 Germany Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
7.3.3 France Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
7.3.5 Russia Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
7.3.6 Italy Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Antibodies Contract Manufacturing Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Antibodies Contract Manufacturing Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Antibodies Contract Manufacturing Market Size by Region
8.3.1 Asia-Pacific Antibodies Contract Manufacturing Consumption Value by Region (2018-2029)
8.3.2 China Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
8.3.3 Japan Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
8.3.4 South Korea Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
8.3.5 India Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
8.3.7 Australia Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Antibodies Contract Manufacturing Consumption Value by Type (2018-2029)
9.2 South America Antibodies Contract Manufacturing Consumption Value by Application (2018-2029)
9.3 South America Antibodies Contract Manufacturing Market Size by Country
9.3.1 South America Antibodies Contract Manufacturing Consumption Value by Country (2018-2029)
9.3.2 Brazil Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
9.3.3 Argentina Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Antibodies Contract Manufacturing Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Antibodies Contract Manufacturing Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Antibodies Contract Manufacturing Market Size by Country
10.3.1 Middle East & Africa Antibodies Contract Manufacturing Consumption Value by Country (2018-2029)
10.3.2 Turkey Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
10.3.4 UAE Antibodies Contract Manufacturing Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Antibodies Contract Manufacturing Market Drivers
11.2 Antibodies Contract Manufacturing Market Restraints
11.3 Antibodies Contract Manufacturing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Antibodies Contract Manufacturing Industry Chain
12.2 Antibodies Contract Manufacturing Upstream Analysis
12.3 Antibodies Contract Manufacturing Midstream Analysis
12.4 Antibodies Contract Manufacturing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Antibodies Contract Manufacturing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Antibodies Contract Manufacturing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Antibodies Contract Manufacturing Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Antibodies Contract Manufacturing Consumption Value by Region (2024-2029) & (USD Million)
Table 5. AMRI Company Information, Head Office, and Major Competitors
Table 6. AMRI Major Business
Table 7. AMRI Antibodies Contract Manufacturing Product and Solutions
Table 8. AMRI Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. AMRI Recent Developments and Future Plans
Table 10. AGC Biologics Company Information, Head Office, and Major Competitors
Table 11. AGC Biologics Major Business
Table 12. AGC Biologics Antibodies Contract Manufacturing Product and Solutions
Table 13. AGC Biologics Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. AGC Biologics Recent Developments and Future Plans
Table 15. Aldevron Company Information, Head Office, and Major Competitors
Table 16. Aldevron Major Business
Table 17. Aldevron Antibodies Contract Manufacturing Product and Solutions
Table 18. Aldevron Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Aldevron Recent Developments and Future Plans
Table 20. Eurofins CDMO Company Information, Head Office, and Major Competitors
Table 21. Eurofins CDMO Major Business
Table 22. Eurofins CDMO Antibodies Contract Manufacturing Product and Solutions
Table 23. Eurofins CDMO Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Eurofins CDMO Recent Developments and Future Plans
Table 25. Boehringer Ingelheim BioXcellence Company Information, Head Office, and Major Competitors
Table 26. Boehringer Ingelheim BioXcellence Major Business
Table 27. Boehringer Ingelheim BioXcellence Antibodies Contract Manufacturing Product and Solutions
Table 28. Boehringer Ingelheim BioXcellence Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Boehringer Ingelheim BioXcellence Recent Developments and Future Plans
Table 30. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 31. FUJIFILM Diosynth Biotechnologies Major Business
Table 32. FUJIFILM Diosynth Biotechnologies Antibodies Contract Manufacturing Product and Solutions
Table 33. FUJIFILM Diosynth Biotechnologies Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
Table 35. Emergent BioSolutions Company Information, Head Office, and Major Competitors
Table 36. Emergent BioSolutions Major Business
Table 37. Emergent BioSolutions Antibodies Contract Manufacturing Product and Solutions
Table 38. Emergent BioSolutions Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Emergent BioSolutions Recent Developments and Future Plans
Table 40. KBI Biopharma Company Information, Head Office, and Major Competitors
Table 41. KBI Biopharma Major Business
Table 42. KBI Biopharma Antibodies Contract Manufacturing Product and Solutions
Table 43. KBI Biopharma Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. KBI Biopharma Recent Developments and Future Plans
Table 45. Lonza Company Information, Head Office, and Major Competitors
Table 46. Lonza Major Business
Table 47. Lonza Antibodies Contract Manufacturing Product and Solutions
Table 48. Lonza Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Lonza Recent Developments and Future Plans
Table 50. Novasep Company Information, Head Office, and Major Competitors
Table 51. Novasep Major Business
Table 52. Novasep Antibodies Contract Manufacturing Product and Solutions
Table 53. Novasep Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Novasep Recent Developments and Future Plans
Table 55. Nitto Avecia Pharma Services Company Information, Head Office, and Major Competitors
Table 56. Nitto Avecia Pharma Services Major Business
Table 57. Nitto Avecia Pharma Services Antibodies Contract Manufacturing Product and Solutions
Table 58. Nitto Avecia Pharma Services Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Nitto Avecia Pharma Services Recent Developments and Future Plans
Table 60. Pierre Fabre Company Information, Head Office, and Major Competitors
Table 61. Pierre Fabre Major Business
Table 62. Pierre Fabre Antibodies Contract Manufacturing Product and Solutions
Table 63. Pierre Fabre Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Pierre Fabre Recent Developments and Future Plans
Table 65. Samsung BioLogics Company Information, Head Office, and Major Competitors
Table 66. Samsung BioLogics Major Business
Table 67. Samsung BioLogics Antibodies Contract Manufacturing Product and Solutions
Table 68. Samsung BioLogics Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Samsung BioLogics Recent Developments and Future Plans
Table 70. Synthon Company Information, Head Office, and Major Competitors
Table 71. Synthon Major Business
Table 72. Synthon Antibodies Contract Manufacturing Product and Solutions
Table 73. Synthon Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Synthon Recent Developments and Future Plans
Table 75. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 76. Thermo Fisher Scientific Major Business
Table 77. Thermo Fisher Scientific Antibodies Contract Manufacturing Product and Solutions
Table 78. Thermo Fisher Scientific Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Thermo Fisher Scientific Recent Developments and Future Plans
Table 80. Global Antibodies Contract Manufacturing Revenue (USD Million) by Players (2018-2023)
Table 81. Global Antibodies Contract Manufacturing Revenue Share by Players (2018-2023)
Table 82. Breakdown of Antibodies Contract Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Antibodies Contract Manufacturing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 84. Head Office of Key Antibodies Contract Manufacturing Players
Table 85. Antibodies Contract Manufacturing Market: Company Product Type Footprint
Table 86. Antibodies Contract Manufacturing Market: Company Product Application Footprint
Table 87. Antibodies Contract Manufacturing New Market Entrants and Barriers to Market Entry
Table 88. Antibodies Contract Manufacturing Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Antibodies Contract Manufacturing Consumption Value (USD Million) by Type (2018-2023)
Table 90. Global Antibodies Contract Manufacturing Consumption Value Share by Type (2018-2023)
Table 91. Global Antibodies Contract Manufacturing Consumption Value Forecast by Type (2024-2029)
Table 92. Global Antibodies Contract Manufacturing Consumption Value by Application (2018-2023)
Table 93. Global Antibodies Contract Manufacturing Consumption Value Forecast by Application (2024-2029)
Table 94. North America Antibodies Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
Table 95. North America Antibodies Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
Table 96. North America Antibodies Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
Table 97. North America Antibodies Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
Table 98. North America Antibodies Contract Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
Table 99. North America Antibodies Contract Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
Table 100. Europe Antibodies Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Europe Antibodies Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Europe Antibodies Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
Table 103. Europe Antibodies Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
Table 104. Europe Antibodies Contract Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Antibodies Contract Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Antibodies Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
Table 107. Asia-Pacific Antibodies Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
Table 108. Asia-Pacific Antibodies Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
Table 109. Asia-Pacific Antibodies Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
Table 110. Asia-Pacific Antibodies Contract Manufacturing Consumption Value by Region (2018-2023) & (USD Million)
Table 111. Asia-Pacific Antibodies Contract Manufacturing Consumption Value by Region (2024-2029) & (USD Million)
Table 112. South America Antibodies Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
Table 113. South America Antibodies Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
Table 114. South America Antibodies Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
Table 115. South America Antibodies Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
Table 116. South America Antibodies Contract Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
Table 117. South America Antibodies Contract Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Middle East & Africa Antibodies Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
Table 119. Middle East & Africa Antibodies Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
Table 120. Middle East & Africa Antibodies Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
Table 121. Middle East & Africa Antibodies Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
Table 122. Middle East & Africa Antibodies Contract Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
Table 123. Middle East & Africa Antibodies Contract Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
Table 124. Antibodies Contract Manufacturing Raw Material
Table 125. Key Suppliers of Antibodies Contract Manufacturing Raw Materials
Table 1. Global Antibodies Contract Manufacturing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Antibodies Contract Manufacturing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Antibodies Contract Manufacturing Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Antibodies Contract Manufacturing Consumption Value by Region (2024-2029) & (USD Million)
Table 5. AMRI Company Information, Head Office, and Major Competitors
Table 6. AMRI Major Business
Table 7. AMRI Antibodies Contract Manufacturing Product and Solutions
Table 8. AMRI Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. AMRI Recent Developments and Future Plans
Table 10. AGC Biologics Company Information, Head Office, and Major Competitors
Table 11. AGC Biologics Major Business
Table 12. AGC Biologics Antibodies Contract Manufacturing Product and Solutions
Table 13. AGC Biologics Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. AGC Biologics Recent Developments and Future Plans
Table 15. Aldevron Company Information, Head Office, and Major Competitors
Table 16. Aldevron Major Business
Table 17. Aldevron Antibodies Contract Manufacturing Product and Solutions
Table 18. Aldevron Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Aldevron Recent Developments and Future Plans
Table 20. Eurofins CDMO Company Information, Head Office, and Major Competitors
Table 21. Eurofins CDMO Major Business
Table 22. Eurofins CDMO Antibodies Contract Manufacturing Product and Solutions
Table 23. Eurofins CDMO Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Eurofins CDMO Recent Developments and Future Plans
Table 25. Boehringer Ingelheim BioXcellence Company Information, Head Office, and Major Competitors
Table 26. Boehringer Ingelheim BioXcellence Major Business
Table 27. Boehringer Ingelheim BioXcellence Antibodies Contract Manufacturing Product and Solutions
Table 28. Boehringer Ingelheim BioXcellence Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Boehringer Ingelheim BioXcellence Recent Developments and Future Plans
Table 30. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 31. FUJIFILM Diosynth Biotechnologies Major Business
Table 32. FUJIFILM Diosynth Biotechnologies Antibodies Contract Manufacturing Product and Solutions
Table 33. FUJIFILM Diosynth Biotechnologies Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
Table 35. Emergent BioSolutions Company Information, Head Office, and Major Competitors
Table 36. Emergent BioSolutions Major Business
Table 37. Emergent BioSolutions Antibodies Contract Manufacturing Product and Solutions
Table 38. Emergent BioSolutions Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Emergent BioSolutions Recent Developments and Future Plans
Table 40. KBI Biopharma Company Information, Head Office, and Major Competitors
Table 41. KBI Biopharma Major Business
Table 42. KBI Biopharma Antibodies Contract Manufacturing Product and Solutions
Table 43. KBI Biopharma Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. KBI Biopharma Recent Developments and Future Plans
Table 45. Lonza Company Information, Head Office, and Major Competitors
Table 46. Lonza Major Business
Table 47. Lonza Antibodies Contract Manufacturing Product and Solutions
Table 48. Lonza Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Lonza Recent Developments and Future Plans
Table 50. Novasep Company Information, Head Office, and Major Competitors
Table 51. Novasep Major Business
Table 52. Novasep Antibodies Contract Manufacturing Product and Solutions
Table 53. Novasep Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Novasep Recent Developments and Future Plans
Table 55. Nitto Avecia Pharma Services Company Information, Head Office, and Major Competitors
Table 56. Nitto Avecia Pharma Services Major Business
Table 57. Nitto Avecia Pharma Services Antibodies Contract Manufacturing Product and Solutions
Table 58. Nitto Avecia Pharma Services Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Nitto Avecia Pharma Services Recent Developments and Future Plans
Table 60. Pierre Fabre Company Information, Head Office, and Major Competitors
Table 61. Pierre Fabre Major Business
Table 62. Pierre Fabre Antibodies Contract Manufacturing Product and Solutions
Table 63. Pierre Fabre Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Pierre Fabre Recent Developments and Future Plans
Table 65. Samsung BioLogics Company Information, Head Office, and Major Competitors
Table 66. Samsung BioLogics Major Business
Table 67. Samsung BioLogics Antibodies Contract Manufacturing Product and Solutions
Table 68. Samsung BioLogics Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Samsung BioLogics Recent Developments and Future Plans
Table 70. Synthon Company Information, Head Office, and Major Competitors
Table 71. Synthon Major Business
Table 72. Synthon Antibodies Contract Manufacturing Product and Solutions
Table 73. Synthon Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Synthon Recent Developments and Future Plans
Table 75. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 76. Thermo Fisher Scientific Major Business
Table 77. Thermo Fisher Scientific Antibodies Contract Manufacturing Product and Solutions
Table 78. Thermo Fisher Scientific Antibodies Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Thermo Fisher Scientific Recent Developments and Future Plans
Table 80. Global Antibodies Contract Manufacturing Revenue (USD Million) by Players (2018-2023)
Table 81. Global Antibodies Contract Manufacturing Revenue Share by Players (2018-2023)
Table 82. Breakdown of Antibodies Contract Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Antibodies Contract Manufacturing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 84. Head Office of Key Antibodies Contract Manufacturing Players
Table 85. Antibodies Contract Manufacturing Market: Company Product Type Footprint
Table 86. Antibodies Contract Manufacturing Market: Company Product Application Footprint
Table 87. Antibodies Contract Manufacturing New Market Entrants and Barriers to Market Entry
Table 88. Antibodies Contract Manufacturing Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Antibodies Contract Manufacturing Consumption Value (USD Million) by Type (2018-2023)
Table 90. Global Antibodies Contract Manufacturing Consumption Value Share by Type (2018-2023)
Table 91. Global Antibodies Contract Manufacturing Consumption Value Forecast by Type (2024-2029)
Table 92. Global Antibodies Contract Manufacturing Consumption Value by Application (2018-2023)
Table 93. Global Antibodies Contract Manufacturing Consumption Value Forecast by Application (2024-2029)
Table 94. North America Antibodies Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
Table 95. North America Antibodies Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
Table 96. North America Antibodies Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
Table 97. North America Antibodies Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
Table 98. North America Antibodies Contract Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
Table 99. North America Antibodies Contract Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
Table 100. Europe Antibodies Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Europe Antibodies Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Europe Antibodies Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
Table 103. Europe Antibodies Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
Table 104. Europe Antibodies Contract Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Antibodies Contract Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Antibodies Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
Table 107. Asia-Pacific Antibodies Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
Table 108. Asia-Pacific Antibodies Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
Table 109. Asia-Pacific Antibodies Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
Table 110. Asia-Pacific Antibodies Contract Manufacturing Consumption Value by Region (2018-2023) & (USD Million)
Table 111. Asia-Pacific Antibodies Contract Manufacturing Consumption Value by Region (2024-2029) & (USD Million)
Table 112. South America Antibodies Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
Table 113. South America Antibodies Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
Table 114. South America Antibodies Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
Table 115. South America Antibodies Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
Table 116. South America Antibodies Contract Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
Table 117. South America Antibodies Contract Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Middle East & Africa Antibodies Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
Table 119. Middle East & Africa Antibodies Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
Table 120. Middle East & Africa Antibodies Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
Table 121. Middle East & Africa Antibodies Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
Table 122. Middle East & Africa Antibodies Contract Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
Table 123. Middle East & Africa Antibodies Contract Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
Table 124. Antibodies Contract Manufacturing Raw Material
Table 125. Key Suppliers of Antibodies Contract Manufacturing Raw Materials
LIST OF FIGURES
Figure 1. Antibodies Contract Manufacturing Picture
Figure 2. Global Antibodies Contract Manufacturing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Antibodies Contract Manufacturing Consumption Value Market Share by Type in 2022
Figure 4. Monoclonal Antibodies
Figure 5. Antibody Fragments
Figure 6. Polyclonal Antibodies
Figure 7. Global Antibodies Contract Manufacturing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Antibodies Contract Manufacturing Consumption Value Market Share by Application in 2022
Figure 9. SME Picture
Figure 10. Large Enterprise Picture
Figure 11. Global Antibodies Contract Manufacturing Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Antibodies Contract Manufacturing Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Antibodies Contract Manufacturing Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Antibodies Contract Manufacturing Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Antibodies Contract Manufacturing Consumption Value Market Share by Region in 2022
Figure 16. North America Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Antibodies Contract Manufacturing Revenue Share by Players in 2022
Figure 22. Antibodies Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Antibodies Contract Manufacturing Market Share in 2022
Figure 24. Global Top 6 Players Antibodies Contract Manufacturing Market Share in 2022
Figure 25. Global Antibodies Contract Manufacturing Consumption Value Share by Type (2018-2023)
Figure 26. Global Antibodies Contract Manufacturing Market Share Forecast by Type (2024-2029)
Figure 27. Global Antibodies Contract Manufacturing Consumption Value Share by Application (2018-2023)
Figure 28. Global Antibodies Contract Manufacturing Market Share Forecast by Application (2024-2029)
Figure 29. North America Antibodies Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Antibodies Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Antibodies Contract Manufacturing Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Antibodies Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Antibodies Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Antibodies Contract Manufacturing Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 39. France Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Antibodies Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Antibodies Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Antibodies Contract Manufacturing Consumption Value Market Share by Region (2018-2029)
Figure 46. China Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 49. India Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Antibodies Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Antibodies Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Antibodies Contract Manufacturing Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Antibodies Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Antibodies Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Antibodies Contract Manufacturing Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 63. Antibodies Contract Manufacturing Market Drivers
Figure 64. Antibodies Contract Manufacturing Market Restraints
Figure 65. Antibodies Contract Manufacturing Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Antibodies Contract Manufacturing in 2022
Figure 68. Manufacturing Process Analysis of Antibodies Contract Manufacturing
Figure 69. Antibodies Contract Manufacturing Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Antibodies Contract Manufacturing Picture
Figure 2. Global Antibodies Contract Manufacturing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Antibodies Contract Manufacturing Consumption Value Market Share by Type in 2022
Figure 4. Monoclonal Antibodies
Figure 5. Antibody Fragments
Figure 6. Polyclonal Antibodies
Figure 7. Global Antibodies Contract Manufacturing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Antibodies Contract Manufacturing Consumption Value Market Share by Application in 2022
Figure 9. SME Picture
Figure 10. Large Enterprise Picture
Figure 11. Global Antibodies Contract Manufacturing Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Antibodies Contract Manufacturing Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Antibodies Contract Manufacturing Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Antibodies Contract Manufacturing Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Antibodies Contract Manufacturing Consumption Value Market Share by Region in 2022
Figure 16. North America Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Antibodies Contract Manufacturing Revenue Share by Players in 2022
Figure 22. Antibodies Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Antibodies Contract Manufacturing Market Share in 2022
Figure 24. Global Top 6 Players Antibodies Contract Manufacturing Market Share in 2022
Figure 25. Global Antibodies Contract Manufacturing Consumption Value Share by Type (2018-2023)
Figure 26. Global Antibodies Contract Manufacturing Market Share Forecast by Type (2024-2029)
Figure 27. Global Antibodies Contract Manufacturing Consumption Value Share by Application (2018-2023)
Figure 28. Global Antibodies Contract Manufacturing Market Share Forecast by Application (2024-2029)
Figure 29. North America Antibodies Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Antibodies Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Antibodies Contract Manufacturing Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Antibodies Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Antibodies Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Antibodies Contract Manufacturing Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 39. France Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Antibodies Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Antibodies Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Antibodies Contract Manufacturing Consumption Value Market Share by Region (2018-2029)
Figure 46. China Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 49. India Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Antibodies Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Antibodies Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Antibodies Contract Manufacturing Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Antibodies Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Antibodies Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Antibodies Contract Manufacturing Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Antibodies Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 63. Antibodies Contract Manufacturing Market Drivers
Figure 64. Antibodies Contract Manufacturing Market Restraints
Figure 65. Antibodies Contract Manufacturing Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Antibodies Contract Manufacturing in 2022
Figure 68. Manufacturing Process Analysis of Antibodies Contract Manufacturing
Figure 69. Antibodies Contract Manufacturing Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
